Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("WANDERS J")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 62

  • Page / 3
Export

Selection :

  • and

CHRONIC MYELOID LEUKEMIA IN MYASTHENIA GRAVIS AFTER LONG-TERM TREATMENT WITH 6-MERCAPTOPURINEWANDERS J; WATTENDORFF AR; ENDTZ LJ et al.1981; ACTA MED. SCAND.; ISSN 0001-6101; SWE; DA. 1981; VOL. 210; NO 3; PP. 235-238; BIBL. 20 REF.Article

The relationship between marking patterns and motivational state in the pre-spawning behaviour of the cichlid fish Chromidotilapia guentheri (Sauvage)BAERENDS, G. P; WANDERS, J. B. W; VODEGEL, R et al.Netherlands journal of zoology. 1986, Vol 36, Num 1, pp 88-116, issn 0028-2960Article

Phase I trial with weekly EO9, a novel bioreductive alkylating indoloquinone, by the EORTC Early Clinical Study Group (ECSG)AAMDAL, S; LUND, B; KOIER, I et al.Cancer chemotherapy and pharmacology. 2000, Vol 45, Num 1, pp 85-88, issn 0344-5704Article

Application of a new multinomial phase II stopping rule using response and early progressionDENT, S; ZEE, B; DANCEY, J et al.Journal of clinical oncology. 2001, Vol 19, Num 3, pp 785-791, issn 0732-183XArticle

Activity of docetaxel (taxotere) in small cell lung cancerSMYTH, J. F; SMITH, I. E; SESSA, C et al.European journal of cancer. Part A. 1994, Vol 30, Num 8, pp 1058-1060Article

A phase I and pharmacokinetic study of indisulam in combination with carboplatinDITTRICH, C; ZANDVLIET, A. S; GNEIST, M et al.British journal of cancer. 2007, Vol 96, Num 4, pp 559-566, issn 0007-0920, 8 p.Article

Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG)TERRET, C; ZANETTA, S; ROCHE, H et al.European journal of cancer (1990). 2003, Vol 39, Num 8, pp 1097-1104, issn 0959-8049, 8 p.Article

Topotecan in colorectal cancer : a phase II study of the EORTC early clinical trials groupCREEMERS, G. J; WANDERS, J; GAMUCCI, T et al.Annals of oncology. 1995, Vol 6, Num 8, pp 844-846, issn 0923-7534Article

Docetaxel (taxotere) in adavanced malignant melanoma :a phase II study of the EORTC eraly clinical trials groupAAMDAL, S; WOLFF, I; KAPLAN, S et al.European journal of cancer. Part A. 1994, Vol 30, Num 8, pp 1061-1064Article

Activity of the dolastatin analogue, LU103793, in malignant melanomaSMYTH, J; BONETERRE, M. E; SCHELLENS, J et al.Annals of oncology. 2001, Vol 12, Num 4, pp 509-511, issn 0923-7534Article

Docetaxel (TaxotereTM) is active in non-small-cell lung cancer : a phase II trial of the EORTC early clinical trials group (ECTG)CERNY, T; KAPLAN, S; PAVLIDIS, N et al.British journal of cancer. 1994, Vol 70, Num 2, pp 384-387, issn 0007-0920Article

Single agent activity of rhizoxin in non-small-cell lung cancer : a phase II trial of the EORTC Early Clinical Trials GroupKAPLAN, S; HANAUSKE, A. R; PAVLIDIS, N et al.British journal of cancer. 1996, Vol 73, Num 3, pp 403-405, issn 0007-0920Article

Phase II study of rhizoxin in squamous cell head and neck cancerVERWEIJ, J; WANDERS, J; GIL, T et al.British journal of cancer. 1996, Vol 73, Num 3, pp 400-402, issn 0007-0920Article

The potential of field spectroscopy for the assessment of sediment properties in river floodplainsKOOISTRA, L; WANDERS, J; EPEMA, G. F et al.Analytica chimica acta. 2003, Vol 484, Num 2, pp 189-200, issn 0003-2670, 12 p.Article

Second-line treatment of small-cell lung cancer with the camptothecin-derivative GI147211 : A study of the EORTC Early Clinical Studies Group (ECSG)SESSA, C; WANDERS, J; ROELVINK, M et al.Annals of oncology. 2000, Vol 11, Num 2, pp 207-210, issn 0923-7534Article

Coping with toxicities of docetaxel (TaxotereTM)SCHRIJVERS, D; WANDERS, J; DIRIX, L et al.Annals of oncology. 1993, Vol 4, Num 7, pp 610-611, issn 0923-7534Article

Validation of high-performance liquid chromatography―tandem mass spectrometry assays for the quantification of eribulin (E7389) in various biological matricesDUBBELMAN, A. C; ROSING, H; THIJSSEN, B et al.Journal of chromatography. B. 2011, Vol 879, Num 15-16, pp 1149-1155, issn 1570-0232, 7 p.Article

Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancerKERBRAT, P; DIERAS, V; PAVLIDIS, N et al.European journal of cancer (1990). 2003, Vol 39, Num 3, pp 317-320, issn 0959-8049, 4 p.Article

An EORTC-ECSG phase I study of LU 79553 administered every 21 or 42 days in patients with solid tumoursAWADA, A; THÖDTMANN, R; PICCART, M. J et al.European journal of cancer (1990). 2003, Vol 39, Num 6, pp 742-747, issn 0959-8049, 6 p.Article

Phase I and pharmacokinetic study of TZT-1027, a novel synthetic dolastatin 10 derivative, administered as a 1-hour intravenous infusion every 3 weeks in patients with advanced refractory cancerSCHÖFFSKI, P; THATE, B; OGUMA, T et al.Annals of oncology. 2004, Vol 15, Num 4, pp 671-679, issn 0923-7534, 9 p.Article

Phase I study of MEN-10755, a new anthracycline in patients with solid tumours : a report from the European Organization for Research and Treatment of Cancer, Early Clinical Studies GroupSCHRIJVERS, D; BOS, A. M. E; DYCK, J et al.Annals of oncology. 2002, Vol 13, Num 3, pp 385-391, issn 0923-7534Article

Docetaxel : an active new drug for treatment of advanced epithelial ovarian cancerPICCART, M. J; GORE, M; TEN BOKKEL HUININK, W et al.Journal of the National Cancer Institute. 1995, Vol 87, Num 9, pp 676-681, issn 0027-8874Article

Docetaxel (Taxotere®) : an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neckCATIMEL, G; VERWEIJ, J; MATTIJSSEN, V et al.Annals of oncology. 1994, Vol 5, Num 6, pp 533-537, issn 0923-7534Article

Docetaxel (taxotere) in advanced renal cell cancer. A phase II trial of the EORTC early clinical trials groupBRUNTSCH, U; HEINRICH, B; VERWEIJ et al.European journal of cancer. Part A. 1994, Vol 30, Num 8, pp 1064-1067Article

UFT and leucovorin in first-line chemotherapy for patients with metastatic gastric cancer. An Early Clinical Studies Group (ECSG)/European Organization for Research Treatment of Cancer (EORTC) phase II trialRAVAUD, A; BORNER, M; SCHELLENS, J. H. M et al.European journal of cancer (1990). 2001, Vol 37, Num 13, pp 1642-1647, issn 0959-8049Article

  • Page / 3